ARSUF (Fagron) Total Receivables: $112 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ARSUF Fagron SA ARSUF
91 GF Score
Price $26.53
GF Value $26.73
! 6 Warning Signs
View Full Analysis

What is Fagron Total Receivables?

Fagron ARSUF -1.74% 91 Total Receivables is $112 Mil as of Dec. 2025. GuruFocus rates ARSUF with a GF Score™ of 91/100 and a GF Value™ of $26.73. The stock has 6 warning signs investors should review.

Fagron's Total Receivables for the quarter that ended in Dec. 2025 was $112 Mil.

Fagron Total Receivables Historical Data

* Premium members only.

The historical data trend for Fagron's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fagron Total Receivables Chart

Fagron Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.64 64.32 67.67 85.83 111.52

Fagron Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.67 93.24 85.83 110.68 111.52
ARSUF
91GF Score
Fagron SA ARSUF
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fagron Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $112 Mil mean?
Fagron (ARSUF) has a Total Receivables of $112 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Fagron and its competitors.
Is Fagron's Total Receivables too high?
Fagron's current Total Receivables is $112 Mil. Overall, Fagron has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Fagron's Total Receivables compare to ZTS and UTHR?
Fagron's Total Receivables of $112 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Fagron and its competitors. Fagron's current Total Receivables is $112 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fagron stock overvalued right now?
Fagron (ARSUF) has a current Total Receivables of $112 Mil. The stock's GF Value™ is $26.73, compared to a current price of $26.53 — trading 0.7% below its estimated fair value. The current Total Receivables is $112 Mil. Fagron's overall GF Score™ is 91/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Fagron (ARSUF), the current Total Receivables is $112 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fagron (ARSUF) Overvalued in 2026?

Based on GuruFocus' analysis, Fagron stock appears to be undervalued. The current stock price of $26.53 is trading 0.7% below its estimated GF Value™ of $26.73.

Key valuation signals for ARSUF:

  • Total Receivables: $112 Mil
  • GF Value™: $26.73 vs. price of $26.53 (0.7% below fair value)
  • GF Score™: 91/100 with 6 warning signs

No single metric tells the full story. See the ARSUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fagron Business Description

Address Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a Belgium-based multinational pharmaceutical compounding company specializing in pharmaceutical compounding. It operates across the pharmaceutical compounding value chain, developing and manufacturing personalized medicines in collaboration with pharmacists, prescribers, hospitals, and other healthcare providers. The company has three segments: Essentials, Brands, and Compounding Services. The majority of the revenue is derived from the Essentials segment, which provides raw materials, equipment, packaging, and supplies for compounding to pharmacies and healthcare industries across EMEA, Latin America, and North America - Pacific. Geographically, it generates the maximum revenue from Fagron North America - Pacific.
91GF Score

Get the complete analysis for ARSUF

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.53
Price
$26.73
GF Value